Neuronetics
STIM
77 hedge funds and large institutions have $56.4M invested in Neuronetics in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 39 reducing their positions, and 13 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less capital invested
Capital invested by funds: $59.9M → $56.4M (-$3.49M)
7% less funds holding
Funds holding: 83 → 77 (-6)
9.72% less ownership
Funds ownership: 74.83% → 65.1% (-9.7%)
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
49% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 39
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Cannell Capital
Alta,
Wyoming
|
+$2.07M |
| 2 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$405K |
| 3 |
E
Ergoteles
New York
|
+$363K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$196K |
| 5 |
FIA
FNY Investment Advisers
New York
|
+$159K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$3.35M |
| 2 |
State Street
Boston,
Massachusetts
|
-$970K |
| 3 |
RA
Royce & Associates
New York
|
-$768K |
| 4 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$691K |
| 5 |
Millennium Management
New York
|
-$555K |
STIM Hedge Fund Activity: Q2 2022 in Review
77 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Neuronetics (STIM) for Q2 2022, worth a combined $56.4M — down 5.8% from $59.9M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of STIM and 9 opened new positions — a net loss of 4 holders — while 39 trimmed existing stakes and 20 added.
The largest buyer was Cannell Capital, adding an estimated $2.07M. The largest seller was BlackRock, cutting an estimated $3.35M.
- 77 institutional investors held Neuronetics (STIM) as of Q2 2022, down from 83 in Q1 2022.
- Funds reported $56.4M of Neuronetics stock for Q2 2022, down 5.8% quarter-over-quarter.
- 9 funds opened new Neuronetics positions in Q2 2022 and 13 closed out, a net change of -4 holders.
- The largest Neuronetics buyer in Q2 2022 was Cannell Capital, an estimated $2.07M added.
- The largest Neuronetics seller in Q2 2022 was BlackRock, an estimated $3.35M sold.
Based on aggregated 13F filings for Q2 2022.